MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway
Pathology - Research and Practice · 2024-09 · 261 · 155471
DOI: 10.1016/j.prp.2024.155471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024-09. Verfasst von Fubin Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Ningxia Medical University, Yinchuan, PR China. Electronic address: dangui1258@163.com. Hauptthemen laut MEDLINE: Stomach Neoplasms, MAP Kinase Signaling System, Cell Proliferation, Cell Movement. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Gansu Province.
Abstract (Originalsprache)
BACKGROUND: Microtubule affinity regulating kinase 4 (MARK4), which is overexpressed in various tumors, is involved in the regulation of cell division, proliferation, migration, and the cell cycle, and has been considered a potential marker for cancer; however, its mechanism of action in gastric cancer (GC) remains unclear. This study aimed to investigate the role of MARK4 in the proliferation, migration, and invasion of GC cell through the MAPK/ERK signaling pathway by targeting MARK4 knockdown. METHODS: Using The Cancer Genome Atlas data and clinical information, MARK4 expression and its relationship with prognosis were analyzed. Possible pathways involving MARK4 were explored using enrichment analysis. Western blotting and real-time quantitative polymerase chain reaction were used to detect MARK4 expression in GC. After targeted transfection of siRNA, the transfection efficiency of the experimental group was detected in AGS and HGC-27 cells. The effects of knockdown MARK4 on the proliferation, migration, and invasion of GC cells were verified using CCK-8, colony formation, wound healing, and transwell assays. Finally, the relationship between MARK4, the MAPK/ERK pathway, and epithelial-mesenchymal transition in GC was verified by western blotting. RESULTS: MARK4 expression was upregulated in GC and associated with poor prognosis in patients with GC. Enrichment analysis showed that MARK4 was involved in the activation of the MAPK signaling pathway. Western blotting results indicated that MARK4 overexpression promoted the proliferation, migration, and invasion of GC cells through the MAPK/ERK pathway. CONCLUSION: MARK4 expression was upregulated in GC and promoted the proliferation, migration, and invasion of GC cells through the MAPK/ERK pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First School of Clinical Medicine, Ningxia Medical University, Yinchuan, PR China. Electronic address: dangui1258@163.com.
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, PR China; Department of Surgical Oncology, Gansu Provincial Hospital, Lanzhou, PR China. Electronic address: 9binbin9@sina.com.
- The First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, PR China. Electronic address: 939079349@qq.com.
- The First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, PR China. Electronic address: 470148034@qq.com.
- The First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, PR China. Electronic address: 17352209403@163.com.
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, PR China; Department of Surgical Oncology, Gansu Provincial Hospital, Lanzhou, PR China. Electronic address: ldyy_damx@lzu.edu.cn.
Förderung
- Natural Science Foundation of Gansu Province
Zitieren
APA
Ma, F., Yao, J., Niu, X., Zhang, J., Shi, D., & Da, M. (2024). MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway. Pathology - Research and Practice, 261, 155471. https://doi.org/10.1016/j.prp.2024.155471
Vancouver
Ma F, Yao J, Niu X, Zhang J, Shi D, Da M. MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway. Pathology - Research and Practice. 2024;261:155471. doi:10.1016/j.prp.2024.155471
BibTeX
@article{Ma2024,
author = {Ma, Fubin and Yao, Jibin and Niu, Xingdong and Zhang, Junrui and Shi, Donghai and Da, Mingxu},
title = {MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway},
journal = {Pathology - Research and Practice},
year = {2024},
volume = {261},
pages = {155471},
doi = {10.1016/j.prp.2024.155471}
}
EUVIMED